Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

FHS
July 14, 2023
9:36 am

Researchers tested the efficacy of a two to three-dose intranasal (IN) regimen of the NDV-HXP-S vaccine.

Pharmalittle: FDA approves BioMarin gene therapy for hemophilia A; former Pfizer worker charged with insider trading

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

June 30, 2023

IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows

The role of type-2 interferon (IFNγ) in antiviral immunity.

December 14, 2023

Rampant Stent Overuse; Hot Tub Heart Risks Revisited; Cardiologist Runs for Office

The American Heart Association said it is officially joining efforts to create a new American Board of Cardiovascular Medicine specific to cardiovascular physicians, alongside other

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.